FDA declines to review potential Celgene MS blockbuster; AstraZeneca to spin off autoimmune drug unit; Justice Department to back prescription opioid lawsuit.
First understanding, next adherence? Using VR to help kids visualize medical findings
Boston Children’s Hospital and Klick Health are unveiling a VR tool to help pediatric patients visualize their disease and symptoms. It could augment the paper-based standard of care.
Five things for pharma marketers to know: Monday, February 26, 2018
FDA approves KemPharm’s Apadaz; Buffett says healthcare alliance will do more than cut out middlemen; Customers unhappy with price of Teva’s Syprine generic.
Virta Health CEO Sami Inkinen on changing patient behavior: ‘We’re cutting down trees in the wrong forest’
Pharma buys back shares with tax savings; Facebook algorithm change means opportunity for patient influencers; Trump claims Azar has already lowered drug prices.
Five things for pharma marketers to know: Thursday, February 22, 2018
Novo Nordisk diabetes pill delivers in late-stage trial; Gilead partners with Sangamo on engineered cell therapies; Study finds antidepressants work, though with varying results.
Five things for pharma marketers to know: Tuesday, February 20, 2018